Media coverage about Phibro Animal Health Corporation (NASDAQ:PAHC) has trended somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies positive and negative press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Phibro Animal Health Corporation earned a media sentiment score of 0.09 on Accern’s scale. Accern also assigned news stories about the company an impact score of 45.7392908216741 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
PAHC has been the topic of a number of research reports. Credit Suisse Group boosted their target price on shares of Phibro Animal Health Corporation from $36.00 to $37.00 and gave the company an “outperform” rating in a report on Thursday, August 31st. Piper Jaffray Companies restated a “buy” rating and set a $41.00 target price (down previously from $42.00) on shares of Phibro Animal Health Corporation in a report on Thursday, August 31st. Bank of America Corporation restated an “underperform” rating and set a $33.00 target price on shares of Phibro Animal Health Corporation in a report on Wednesday, August 23rd. Finally, BidaskClub cut shares of Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a report on Wednesday, August 23rd. Two analysts have rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the stock. Phibro Animal Health Corporation has a consensus rating of “Hold” and an average price target of $33.00.
Shares of Phibro Animal Health Corporation (NASDAQ PAHC) traded up 0.40% during trading on Thursday, reaching $37.20. 48,300 shares of the company were exchanged. Phibro Animal Health Corporation has a 1-year low of $24.85 and a 1-year high of $40.25. The firm has a market capitalization of $1.48 billion, a P/E ratio of 23.11 and a beta of 1.36. The firm’s 50 day moving average is $36.66 and its 200 day moving average is $35.66.
Phibro Animal Health Corporation (NASDAQ:PAHC) last posted its quarterly earnings data on Wednesday, August 30th. The company reported $0.39 earnings per share for the quarter, topping analysts’ consensus estimates of $0.35 by $0.04. Phibro Animal Health Corporation had a return on equity of 47.88% and a net margin of 8.45%. The company had revenue of $194.84 million during the quarter, compared to analysts’ expectations of $192.47 million. During the same period last year, the firm earned $0.32 EPS. The firm’s revenue for the quarter was up 3.0% on a year-over-year basis. On average, equities analysts anticipate that Phibro Animal Health Corporation will post $1.56 EPS for the current fiscal year.
In other news, CFO Richard G. Johnson sold 55,529 shares of the firm’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $36.30, for a total value of $2,015,702.70. Following the completion of the sale, the chief financial officer now directly owns 15,900 shares of the company’s stock, valued at approximately $577,170. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Daniel M. Bendheim sold 1,443 shares of the firm’s stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $40.05, for a total value of $57,792.15. Following the completion of the sale, the vice president now directly owns 300 shares of the company’s stock, valued at $12,015. The disclosure for this sale can be found here. Insiders have sold a total of 292,448 shares of company stock valued at $10,624,994 over the last ninety days. 51.88% of the stock is owned by insiders.
TRADEMARK VIOLATION WARNING: “Phibro Animal Health Corporation (NASDAQ:PAHC) Earning Somewhat Positive Media Coverage, Report Finds” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at https://www.dispatchtribunal.com/2017/10/26/phibro-animal-health-corporation-pahc-earning-somewhat-favorable-press-coverage-analysis-finds.html.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.